Lancet Oncology
Journal Abbreviation: LANCET ONCOL
ISSN: 1470-2045
eISSN: 1474-5488
Publisher: Elsevier: Lancet
Publications (39)
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial (2025)
Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, et al.
Journal article
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey. (2025)
Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, et al.
Journal article
A brave new framework for glioma drug development (2024)
Hotchkiss KM, Karschnia P, Schreck KC, Geurts M, Cloughesy TF, Huse J, Duke ES, et al.
Journal article, Review article
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group (2024)
Karschnia P, Gerritsen JK, Teske N, Cahill DP, Jakola AS, van den Bent M, Weller M, et al.
Journal article, Review article
Carcinogenicity of talc and acrylonitrile. (2024)
Stayner LT, Carreón-Valencia T, Demers PA, Fritz JM, Sim MR, Stewart P, Tsuda H, et al.
Journal article
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups (2023)
Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, et al.
Journal article, Review article
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study (2023)
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, et al.
Journal article
Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial (2023)
Strnad V, Polgár C, Ott O, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al.
Journal article
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study (2023)
Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, et al.
Journal article
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial (2023)
Grimm MO, Grün CB, Niegisch G, Pichler M, Roghmann F, Schmitz-Dräger B, Baretton G, et al.
Journal article